-
Something wrong with this record ?
Antioxidant defense in quiescent cells determines selectivity of electron transport chain inhibition-induced cell death
J. Blecha, SM. Novais, K. Rohlenova, E. Novotna, S. Lettlova, S. Schmitt, H. Zischka, J. Neuzil, J. Rohlena,
Language English Country United States
Document type Journal Article
Grant support
NV16-31604A
MZ0
CEP Register
- MeSH
- Adenosine Triphosphate metabolism MeSH
- Cell Death genetics MeSH
- Cell Respiration MeSH
- Cell Cycle genetics MeSH
- Electron Transport Chain Complex Proteins genetics metabolism MeSH
- Endothelial Cells cytology metabolism MeSH
- Epithelial Cells cytology metabolism MeSH
- Gene Expression MeSH
- Glucose metabolism MeSH
- Humans MeSH
- Mitochondria metabolism MeSH
- Cell Line, Tumor MeSH
- Oxidation-Reduction MeSH
- Reactive Oxygen Species metabolism MeSH
- Superoxide Dismutase genetics metabolism MeSH
- Thioredoxins genetics metabolism MeSH
- Cell Line, Transformed MeSH
- Electron Transport MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Mitochondrial electron transport chain (ETC) targeting shows a great promise in cancer therapy. It is particularly effective in tumors with high ETC activity where ETC-derived reactive oxygen species (ROS) are efficiently induced. Why modern ETC-targeted compounds are tolerated on the organismal level remains unclear. As most somatic cells are in non-proliferative state, the features associated with the ETC in quiescence could account for some of the specificity observed. Here we report that quiescent cells, despite increased utilization of the ETC and enhanced supercomplex assembly, are less susceptible to cell death induced by ETC disruption when glucose is not limiting. Mechanistically, this is mediated by the increased detoxification of ETC-derived ROS by mitochondrial antioxidant defense, principally by the superoxide dismutase 2 - thioredoxin axis. In contrast, under conditions of glucose limitation, cell death is induced preferentially in quiescent cells and is correlated with intracellular ATP depletion but not with ROS. This is related to the inability of quiescent cells to compensate for the lost mitochondrial ATP production by the upregulation of glucose uptake. Hence, elevated ROS, not the loss of mitochondrially-generated ATP, are responsible for cell death induction by ETC disruption in ample nutrients condition, e.g. in well perfused healthy tissues, where antioxidant defense imparts specificity. However, in conditions of limited glucose, e.g. in poorly perfused tumors, ETC disruption causes rapid depletion of cellular ATP, optimizing impact towards tumor-associated dormant cells. In summary, we propose that antioxidant defense in quiescent cells is aided by local glucose limitations to ensure selectivity of ETC inhibition-induced cell death.
Faculty of Science Charles University Prague Czech Republic
Institute of Biotechnology Czech Academy of Sciences BIOCEV Vestec Prague West Czech Republic
Institute of Toxicology and Environmental Hygiene Technical University Munich Munich Germany
School of Medical Science Griffith University Southport Qld Australia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18024763
- 003
- CZ-PrNML
- 005
- 20180716093504.0
- 007
- ta
- 008
- 180709s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.freeradbiomed.2017.07.033 $2 doi
- 035 __
- $a (PubMed)28774815
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Blecha, Jan $u Institute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Prague-West, Czech Republic; Faculty of Science, Charles University, Prague, Czech Republic.
- 245 10
- $a Antioxidant defense in quiescent cells determines selectivity of electron transport chain inhibition-induced cell death / $c J. Blecha, SM. Novais, K. Rohlenova, E. Novotna, S. Lettlova, S. Schmitt, H. Zischka, J. Neuzil, J. Rohlena,
- 520 9_
- $a Mitochondrial electron transport chain (ETC) targeting shows a great promise in cancer therapy. It is particularly effective in tumors with high ETC activity where ETC-derived reactive oxygen species (ROS) are efficiently induced. Why modern ETC-targeted compounds are tolerated on the organismal level remains unclear. As most somatic cells are in non-proliferative state, the features associated with the ETC in quiescence could account for some of the specificity observed. Here we report that quiescent cells, despite increased utilization of the ETC and enhanced supercomplex assembly, are less susceptible to cell death induced by ETC disruption when glucose is not limiting. Mechanistically, this is mediated by the increased detoxification of ETC-derived ROS by mitochondrial antioxidant defense, principally by the superoxide dismutase 2 - thioredoxin axis. In contrast, under conditions of glucose limitation, cell death is induced preferentially in quiescent cells and is correlated with intracellular ATP depletion but not with ROS. This is related to the inability of quiescent cells to compensate for the lost mitochondrial ATP production by the upregulation of glucose uptake. Hence, elevated ROS, not the loss of mitochondrially-generated ATP, are responsible for cell death induction by ETC disruption in ample nutrients condition, e.g. in well perfused healthy tissues, where antioxidant defense imparts specificity. However, in conditions of limited glucose, e.g. in poorly perfused tumors, ETC disruption causes rapid depletion of cellular ATP, optimizing impact towards tumor-associated dormant cells. In summary, we propose that antioxidant defense in quiescent cells is aided by local glucose limitations to ensure selectivity of ETC inhibition-induced cell death.
- 650 _2
- $a adenosintrifosfát $x metabolismus $7 D000255
- 650 _2
- $a buněčný cyklus $x genetika $7 D002453
- 650 _2
- $a buněčná smrt $x genetika $7 D016923
- 650 _2
- $a transformované buněčné linie $7 D002461
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a buněčné dýchání $7 D019069
- 650 _2
- $a transport elektronů $7 D004579
- 650 _2
- $a elektronový transportní řetězec $x genetika $x metabolismus $7 D045222
- 650 _2
- $a endoteliální buňky $x cytologie $x metabolismus $7 D042783
- 650 _2
- $a epitelové buňky $x cytologie $x metabolismus $7 D004847
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a glukosa $x metabolismus $7 D005947
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mitochondrie $x metabolismus $7 D008928
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 650 _2
- $a superoxiddismutasa $x genetika $x metabolismus $7 D013482
- 650 _2
- $a thioredoxiny $x genetika $x metabolismus $7 D013879
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Novais, Silvia Magalhaes $u Institute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Prague-West, Czech Republic.
- 700 1_
- $a Rohlenova, Katerina $u Institute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Prague-West, Czech Republic.
- 700 1_
- $a Novotna, Eliska $u Institute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Prague-West, Czech Republic.
- 700 1_
- $a Lettlova, Sandra $u Institute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Prague-West, Czech Republic.
- 700 1_
- $a Schmitt, Sabine $u Institute of Toxicology and Environmental Hygiene, Technical University Munich, Munich, Germany.
- 700 1_
- $a Zischka, Hans $u Institute of Toxicology and Environmental Hygiene, Technical University Munich, Munich, Germany; Institute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, D-85764 Neuherberg, Germany.
- 700 1_
- $a Neuzil, Jiri $u Institute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Prague-West, Czech Republic; School of Medical Science, Griffith University, Southport, Qld, Australia. Electronic address: j.neuzil@griffith.edu.au.
- 700 1_
- $a Rohlena, Jakub $u Institute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Prague-West, Czech Republic. Electronic address: jakub.rohlena@ibt.cas.cz.
- 773 0_
- $w MED00001857 $t Free radical biology & medicine $x 1873-4596 $g Roč. 112, č. - (2017), s. 253-266
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28774815 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180716093802 $b ABA008
- 999 __
- $a ok $b bmc $g 1316894 $s 1021684
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 112 $c - $d 253-266 $e 20170731 $i 1873-4596 $m Free radical biology & medicine $n Free Radic Biol Med $x MED00001857
- GRA __
- $a NV16-31604A $p MZ0
- LZP __
- $a Pubmed-20180709